VERA LEE: Open Payments
NPI 1215437223 · SAN JOSE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,269 in 100 payments from 15 companies in 2025. Trend: 2023 $362 · 2024 $736 · 2025 $3,269
Food & beverage: $3,113Education: $157
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 22 | $587 |
| Arcutis Biotherapeutics, Inc. | 8 | $573 |
| GENZYME CORPORATION | 9 | $365 |
| Novartis Pharmaceuticals Corporation | 10 | $291 |
| ABBVIE INC. | 10 | $238 |
| Galderma Laboratories, L.P. | 5 | $238 |
| Regeneron Healthcare Solutions, Inc. | 11 | $230 |
| PFIZER INC. | 9 | $223 |
| Incyte Corporation | 5 | $182 |
| SANOFI-AVENTIS U.S. LLC | 1 | $99 |
Products named: DUPIXENT, TREMFYA, Zoryve, CIBINQO, COSENTYX, NEMLUVIO, OPZELURA, SKYRIZI.
Industry payments across CA — which companies pay providers there.
